Chemical Compound

Ondansetron Impurity B

CAS Registry Number 1076198-52-1
Ondansetron Impurity B chemical structure
Primary Record

Ondansetron Impurity B

In stock
1,292 g
Purity
99.4 %
CAS
1076198-52-1

Compound Identifiers & Properties

CAS
1076198-52-1
PubChem CID
46782240
SMILES
CC1=NC=CN1CC2CCC3=C(C2=O)C4=C(N3C)C=CC(=C4)CC5=CC6=C(C=C5)N(C7=C6C(=O)C(CC7)CN8C=CN=C8C)C
Canonical SMILES
Cc1nccn1CC1CCc2c(c3cc(Cc4ccc5c(c4)c4c(n5C)CCC(Cn5ccnc5C)C4=O)ccc3n2C)C1=O

Names & Synonyms

  • Ondansetron Impurity B
  • Ondansetron Dimer
  • Ondansetron EP Impurity B
  • 1076198-52-1
  • (Ondansetron Impurity B)
  • RefChem:1073560
  • (Ondansetron Impurity B)"
  • UNII-83UCA3Y462
  • 83UCA3Y462
  • DTXSID901112429
  • SCHEMBL19106873
  • CTK8G2186
  • DTXCID201544035
  • 6,6'-Methylenebis((3RS)-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one)
  • H36334
  • 2-Methylacrylic Acid 3-Phenyloxetan-3-yl Ester
  • 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-6-[[9-methyl-6-[(2-methylimidazol-1-yl)methyl]-5-oxo-7,8-dihydro-6H-carbazol-3-yl]methyl]-2,3-dihydro-1H-carbazol-4-one
  • Ondansetron hydrochloride dihydrate specified impurity B [EP]
  • Q27269452
  • 4H-Carbazol-4-one, 6,6'-methylenebis(1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-
  • 6,6'-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one]
  • B1370-244743
  • 6,6'-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one
  • ONDANSETRON HYDROCHLORIDE DIHYDRATE IMPURITY B [EP IMPURITY]
  • 6,6'-Methylenebis(9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one)
  • 6,6'-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazo
  • 6,6'-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one(Ondansetron Impurity B)
  • 6,6 inverted exclamation marka-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one]
  • 6,6'-Methylenebis(1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one)
  • 6,6'-methylenebis(9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one)
  • 6,6'-Methylenebis[(2RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one
  • 6,6'-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one (Ondansetron Impurity B)
  • 6,6'-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one
  • 6,6'-Methylenebis{9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one}
  • 6,6a(2)-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one]
  • Ondansetron Hydrochloride Dihydrate Imp. B (EP); Ondansetron Imp. B (EP); 6,6'-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one]; Ondansetron Hydrochloride Dihydrate Impurity B; Ondansetron Impurity B